Prochlorperazine edisylate

乙二磺酸丙氯拉嗪

Report date: 2022/01/14 13:23:58
NME

Base Information

Drug NameProchlorperazine edisylate
Drug Alias Name甲呱氯丙嗪乙二磺酸盐Edisilato de proclorperazinaProchlorpemazine EdisylateProchlorperazine EdisilateProchlorperazine Edisylate +[9] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionDopamine D2 receptor antagonists
TargetsDopamine D2 receptor
Therapy Area/IndicationsSchizophreniaAnxiety DisordersNausea
Global Approved IndicationsSchizophreniaAnxiety DisordersNausea
Approved Indications in ChinaN/A
Original Approved Country/TerritoryUnited States
Original Approved Date1957/04/08
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesGlaxosmithkline Plc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGlaxosmithkline Plc
Active IndicationsN/A
Inactive IndicationsSchizophreniaAnxiety DisordersNausea

Other Information

ATC CodeN05AB04
Related LinksWikipediaDrugBankKEGG